These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1419820)

  • 1. Cellular and humoral immune responses in haemophiliacs after vaccination against tick-borne encephalitis.
    Wolf HM; Pum M; Jáger R; István L; Mannhalter JW; Eibl MM
    Br J Haematol; 1992 Oct; 82(2):374-83. PubMed ID: 1419820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of antibodies after vaccination against tick-borne encephalitis.
    Rendi-Wagner P; Zent O; Jilg W; Plentz A; Beran J; Kollaritsch H
    Int J Med Microbiol; 2006 May; 296 Suppl 40():202-7. PubMed ID: 16524776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias.
    Garner-Spitzer E; Seidl-Friedrich C; Zwazl I; Hofer M; Kinaciyan T; Jarisch R; Stiasny K; Zlabinger GJ; Kundi M; Wiedermann U
    Vaccine; 2018 May; 36(20):2816-2824. PubMed ID: 29673942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA).
    Prelog M; Almanzar G; Stern R; Robrade K; Holzer MT; Winzig C; Kleines M; Stiasny K; Meyer T; Speth F; Haas JP
    Vaccine; 2021 Sep; 39(40):5918-5927. PubMed ID: 34462165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine.
    Hopf S; Garner-Spitzer E; Hofer M; Kundi M; Wiedermann U
    Vaccine; 2016 Apr; 34(17):2027-34. PubMed ID: 26768126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection.
    Baldovin T; Mel R; Bertoncello C; Carpenè G; Soppelsa F; Giliberti A; Baldo V
    J Med Virol; 2012 Aug; 84(8):1274-8. PubMed ID: 22711356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Wiedermann U; Laaber B; Kollaritsch H
    Vaccine; 2007 Jun; 25(27):5097-101. PubMed ID: 17555850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety.
    Beran J; Xie F; Zent O
    Vaccine; 2014 Jul; 32(34):4275-80. PubMed ID: 24950352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
    Poellabauer E; Angermayr R; Behre U; Zhang P; Harper L; Schmitt HJ; Erber W
    Vaccine; 2019 May; 37(24):3241-3250. PubMed ID: 30928173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
    Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
    Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10.
    Garner-Spitzer E; Wagner A; Paulke-Korinek M; Kollaritsch H; Heinz FX; Redlberger-Fritz M; Stiasny K; Fischer GF; Kundi M; Wiedermann U
    J Immunol; 2013 Sep; 191(5):2426-36. PubMed ID: 23872054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
    Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
    Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.
    Bröker M; Kollaritsch H
    Vaccine; 2008 Feb; 26(7):863-8. PubMed ID: 18206274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against tick-borne encephalitis virus tests specific IgG production ability in patients under immunoglobulin substitution therapy.
    Seidel MG; Grohmann E; Sadeghi K; Pollak A; Heitger A; Förster-Waldl E
    Vaccine; 2010 Sep; 28(40):6621-6. PubMed ID: 20656033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome and cerebrospinal fluid profiles in patients with tick-borne encephalitis and prior vaccination history.
    Lenhard T; Ott D; Jakob NJ; Martinez-Torres F; Grond-Ginsbach C; Meyding-Lamadé U
    Ticks Tick Borne Dis; 2018 May; 9(4):882-888. PubMed ID: 29576392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.